Molecular mechanisms of paclitaxel and NM-3 on human gastric cancer in a severe combined immune deficiency mice orthotopic implantation model

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

203

HTML

1470

Figures (1-2)

203

Tables (1-2)

178

Sum=2054

Aug 14, 2007 (publication date) through Nov 5, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Aug 14, 2007; 13(30): 4131-4135
Published online Aug 14, 2007. doi: 10.3748/wjg.v13.i30.4131

Table 1 Effects of paclitaxel/NM-3 on the cell cycle progression (mean ± SD)

^aP > 0.05 vs saline group;

^bP < 0.01 vs paclitaxel group).

Citation: Zhu JS, Song MQ, Chen GQ, Li Q, Sun Q, Zhang Q. Molecular mechanisms of paclitaxel and NM-3 on human gastric cancer in a severe combined immune deficiency mice orthotopic implantation model. World J Gastroenterol 2007; 13(30): 4131-4135
URL: https://www.wjgnet.com/1007-9327/full/v13/i30/4131.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i30.4131